Published February 13, 2023
| Version 1.0.0
Dataset
Open
Screening for nucleoside inhibitors of the SARS-CoV-2 RdRP
Description
This report describes the most relevant results of screening compounds with a nucleoside analogue structure from the Janssen Pharmaceutica compound collection for potential activity against SARS-CoV-2 in a cell-based assay and nucleoside triphosphates in a radioactive filtering binding RdRP assay.
Files
Files
(298.5 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:5f82b327e7738a57b66318493f4158b0
|
298.5 kB | Download |